Genome-wide association studies (GWAS) have been successful in finding associations between specific genetic variants and cancer susceptibility in human populations. These studies have identified a range of highly statistically significant associations between single nucleotide polymorphisms (SNPs) and susceptibility to development of a range of human tumors. However, the effect of each SNP in isolation is very small, and all of the SNPs combined only account for a relatively minor proportion of the total genetic risk (5-10%). There is therefore a major requirement for alternative routes to the discovery of genetic risk factors for cancer. We have previously shown using mouse models that chromosomal regions harboring susceptibility genes id...
Mouse models of cancers are routinely used to study cancer biology. However, it remains unclear whet...
Mutations in the p53 tumor suppressor gene are found in over 50% of human tumors and in the germline...
Secondary malignancies are a serious adverse consequence of alkylator chemotherapy. The risk of deve...
Genome-wide association studies (GWAS) have been successful in finding associations between specific...
BACKGROUND: The p53 tumor suppressor gene is mutated in a large percentage of human malignancies, in...
Abstract Background A variety of skin cancer susceptibility among mouse strains has allowed identifi...
Genome-wide screening by genetic marker analysis in crosses between well-characterized mouse strains...
Tumors frequently exhibit loss of tumor suppressor genes or allelic gains of activated oncogenes. A ...
Highly rearranged and mutated cancer genomes present major challenges in the identification of patho...
Abstract: Genome-wide association studies have revealed that many low-penetrance cancer susceptibili...
Secondary malignancies are a serious adverse consequence of alkylator chemotherapy. The risk of deve...
FBXW7 is the substrate recognition component of a SCF-type E3 ubiquitin ligase. It has multiple targ...
Background: Tumors frequently exhibit loss of tumor suppressor genes or allelic gains of activated o...
Mutations in the p53 tumor suppressor gene are found in over 50% of human tumors and in the germline...
FBXW7 is the substrate recognition component of a SCF-type E3 ubiquitin ligase. It has multiple targ...
Mouse models of cancers are routinely used to study cancer biology. However, it remains unclear whet...
Mutations in the p53 tumor suppressor gene are found in over 50% of human tumors and in the germline...
Secondary malignancies are a serious adverse consequence of alkylator chemotherapy. The risk of deve...
Genome-wide association studies (GWAS) have been successful in finding associations between specific...
BACKGROUND: The p53 tumor suppressor gene is mutated in a large percentage of human malignancies, in...
Abstract Background A variety of skin cancer susceptibility among mouse strains has allowed identifi...
Genome-wide screening by genetic marker analysis in crosses between well-characterized mouse strains...
Tumors frequently exhibit loss of tumor suppressor genes or allelic gains of activated oncogenes. A ...
Highly rearranged and mutated cancer genomes present major challenges in the identification of patho...
Abstract: Genome-wide association studies have revealed that many low-penetrance cancer susceptibili...
Secondary malignancies are a serious adverse consequence of alkylator chemotherapy. The risk of deve...
FBXW7 is the substrate recognition component of a SCF-type E3 ubiquitin ligase. It has multiple targ...
Background: Tumors frequently exhibit loss of tumor suppressor genes or allelic gains of activated o...
Mutations in the p53 tumor suppressor gene are found in over 50% of human tumors and in the germline...
FBXW7 is the substrate recognition component of a SCF-type E3 ubiquitin ligase. It has multiple targ...
Mouse models of cancers are routinely used to study cancer biology. However, it remains unclear whet...
Mutations in the p53 tumor suppressor gene are found in over 50% of human tumors and in the germline...
Secondary malignancies are a serious adverse consequence of alkylator chemotherapy. The risk of deve...